Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

EuSoMII/Bracco AI Contest Pisa, Italy, on the 13th and 14th of October 2023, the European Society of Medical Imaging Informatics hosted its annual gathering. Aptly titled "AI: Connecting the dots," this event brought together minds from different corners of the medical and radiology world to explore the boundless possibilities of Artificial Intelligence.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Sustainability - Staging The health and wellbeing of all is our Purpose. Through continuous innovation we guarantee cutting-edge products and sustainable processes. Our manifesto represents the map of our path: the vision that inspires our every day. From there, everything else follows.

Innovation in Healthcare Industry and Diagnostic Imaging Innovation is at the heart of Bracco’s activities. The company invited experts to discuss how artificial intelligence (AI) can help develop medicines faster and improve diagnostic accuracy in a dedicated Innovation Day last September.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.

How Bracco Reached New Heights in 2023 "Customer support, innovation, and sustainability marked 2023" according to Cosimo De Pinto, Senior Vice President of Sales and Marketing at Bracco Diagnostics Inc., who was interviewed by Editor-in-Chief Melisande Rouger of Diagnostic Imaging Europe straight after RSNA2023.